Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Siam Wellness Group Public Company Limited (SPA.BK)
Bangkok, TH
Siam Wellness Group Public Company Limited, established in Bangkok, Thailand, in 2001, is a prominent enterprise focused on the health spa and broader wellness industry. The company oversees a diverse portfolio of operations, including the luxurious RarinJinda Wellness Spa, the widely known Let's Relax day spa service, traditional Baan Suan Massage centers, and specialized stretching facilities under "Stretch me by Let's Relax" and "Stretch me Clinic." Their offerings also extend to hospitality, with the RarinJinda Wellness Spa Resort boutique hotel, along with the Deck One restaurant and ORB cafe located in Chiang Mai. For skincare, they feature Dr. Spiller Pure Skin Care Solutions for facial treatments, and they also run the Siam Wellness Thai Massage and Spa School. In addition to services, the group manufactures and distributes a wide range of spa and therapeutic personal care products, such as massage oils, body masks, natural soaps, shower gels, hand creams, and aroma sprays, all under the Let's Relax Lifestyle brands. Their product line further encompasses facial, body, slimming, wax, and nail care items, as well as professional spa equipment like electric blankets and massage bed sheets. These products are supplied to various establishments including hair salons, beauty clinics, hospitals, and other spas. The company also provides management and consultancy services. By December 31, 2021, Siam Wellness Group operated a total of 70 branches, with 65 located within Thailand and 5 situated internationally.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.95% | -3.21% | +0.00% | -21.35% | +3.42% | -1.95% | +0.00% | -58.80% | -39.60% | -23.16% | +33.04% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 4 | -1 |
| Hold | 0 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Personal Products & Services: +6.6%-0.4% Q1'26: +26.8% (vs Q1'25)
-
EPS growth Personal Products & Services: +19.6%-37.5% Q1'26: +8.7% (vs Q1'25)
-
FCF margin FCF growth · Personal Products & Services: +11.7%+10.9% Q1'26: +24.8% (vs Q1'25)
-
EBIT margin Personal Products & Services: +10.5%+15.0% ★ Q1'26: +15.6% (vs Q1'25)
-
ROIC Personal Products & Services: +6.9%+7.1% ★ Q1'26: +11.1% (vs Q1'25)
-
Share dilution Personal Products & Services: +0.0%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Personal Products & Services: 0.59×3.13× Q1'26: 1.80× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 5 EPS Ana. |
Dec 2027 6 Rev. Ana. 6 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
533.24M
est: 537.67M (-0.8%)
|
725.19M
est: 735.73M (-1.4%)
|
947.64M
est: 964.62M (-1.8%)
|
1.13B
est: 1.18B (-3.7%)
|
1.38B
est: 1.43B (-3.2%)
|
426.91M
est: 437.11M (-2.3%)
|
167.61M
est: 164.80M (+1.7%)
|
711.28M
est: 632.74M (+12.4%)
|
1.45B
est: 1.58B (-8.2%)
|
1.63B
est: 1.74B (-6.2%)
|
1.62B
est: 1.57B (+3.3%)
|
1.75B
1.71B – 1.81B
+11.5% YoY
|
1.98B
1.87B – 2.13B
+13.1% YoY
|
2.33B
2.24B – 2.46B
+17.7% YoY
|
| EBITDA |
173.78M
est: 180.67M (-3.8%)
|
220.70M
est: 247.23M (-10.7%)
|
289.94M
est: 324.14M (-10.6%)
|
345.84M
est: 395.75M (-12.6%)
|
413.57M
est: 480.33M (-13.9%)
|
16.71M
est: 146.88M (-88.6%)
|
73.56M
est: 55.38M (+32.8%)
|
273.65M
est: 212.62M (+28.7%)
|
599.20M
est: 618.57M (-3.1%)
|
656.68M
est: 682.32M (-3.8%)
|
523.49M
est: 616.73M (-15.1%)
|
687.75M
671.18M – 710.48M
+11.5% YoY
|
777.98M
734.33M – 837.16M
+13.1% YoY
|
915.43M
877.98M – 966.37M
+17.7% YoY
|
| EBIT |
134.76M
est: -136.54M (+198.7%)
|
165.40M
est: -186.84M (+188.5%)
|
212.49M
est: -244.97M (+186.7%)
|
249.88M
est: -299.09M (+183.5%)
|
298.01M
est: -363.01M (+182.1%)
|
-189.67M
est: -111.01M (-70.9%)
|
-251.27M
est: -41.85M (-500.4%)
|
-36.71M
est: -160.69M (+77.2%)
|
324.54M
est: -136.06M (+338.5%)
|
400.38M
est: -150.09M (+366.8%)
|
242.69M
est: -135.66M (+278.9%)
|
-151.28M
-156.28M – -147.64M
-11.5% YoY
|
-171.13M
-184.15M – -161.53M
-13.1% YoY
|
-201.36M
-212.57M – -193.12M
-17.7% YoY
|
| Net Income |
106.49M
est: 113.40M (-6.1%)
|
140.96M
est: 144.40M (-2.4%)
|
175.17M
est: 178.55M (-1.9%)
|
205.60M
est: 220.87M (-6.9%)
|
245.47M
est: 248.19M (-1.1%)
|
-209.09M
est: -186.31M (-12.2%)
|
-286.72M
est: -303.53M (+5.5%)
|
-88.03M
est: -94.32M (+6.7%)
|
332.14M
est: 357.15M (-7.0%)
|
309.14M
est: 332.25M (-7.0%)
|
188.70M
est: 188.70M (+0.0%)
|
228.28M
216.19M – 258.09M
+21.0% YoY
|
254.47M
249.87M – 291.51M
+11.5% YoY
|
336.64M
315.71M – 357.57M
+32.3% YoY
|
| SGA |
73.77M
est: 139.80M (-47.2%)
|
89.04M
est: 191.30M (-53.5%)
|
130.34M
est: 250.81M (-48.0%)
|
152.48M
est: 306.22M (-50.2%)
|
162.57M
est: 371.66M (-56.3%)
|
118.66M
est: 113.65M (+4.4%)
|
107.69M
est: 42.85M (+151.3%)
|
127.16M
est: 164.52M (-22.7%)
|
138.69M
est: 357.60M (-61.2%)
|
170.94M
est: 394.46M (-56.7%)
|
183.51M
est: 356.54M (-48.5%)
|
397.60M
388.02M – 410.74M
+11.5% YoY
|
449.76M
424.52M – 483.98M
+13.1% YoY
|
529.22M
507.57M – 558.67M
+17.7% YoY
|
| EPS |
0.08
est: 0.09 (-6.1%)
|
0.11
est: 0.11 (-2.3%)
|
0.14
est: 0.14 (+0.6%)
|
0.16
est: 0.17 (-7.1%)
|
0.19
est: 0.19 (-1.8%)
|
-0.16
est: -0.15 (-10.1%)
|
-0.22
est: -0.24 (+7.0%)
|
-0.07
est: -0.07 (+7.8%)
|
0.26
est: 0.28 (-6.6%)
|
0.24
est: 0.26 (-6.5%)
|
0.15
est: 0.14 (+10.3%)
|
0.19
0.17 – 0.20
+38.1% YoY
|
0.21
0.19 – 0.23
+13.1% YoY
|
0.26
0.25 – 0.28
+22.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-21 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-20 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-19 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-18 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-15 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-14 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-13 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-12 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-11 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-08 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-07 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-06 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-05 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-30 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-29 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-28 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-27 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-24 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-23 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 57.1K | 0.39% |
| 2 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 60.7K | 0.28% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Thanit Amorntirasan | Executive Director | 490.0K | female |
| Narun Wiwattanakrai | CMO, Deputy MD, Chief Administrative Officer, Head of Risk Working Group & Director | 352.0K | male |
| Prasert Jiravanstit | MD & Executive Director | 352.0K | male |
| Wiboon Utsahajit | Chief Executive Officer, President & Executive Director | 346.0K | male |
| Prin Ekmanochai | Assistant MD, Legal Director (Chief Legal Officer) & Company Secretary | — | male |
| Siriwan Kongchamnanlikit | Head of Human Resources Department | — | female |
| Yonlawan Ahemalongkorn | Chief Financial Officer & Assistant MD | — | female |
| Attaporn Dhanasarnsilp | Head of Sales Department | — | female |
| Yonlawan Eiamlongkorn | Chief Financial Officer & Assistant MD | — | female |
| Chutaporn Jiravanstit | Chief Project Officer, Chief Operating Officer, Assistant MD | — | female |
| Kulsiri Chongviwatthanatham | Accounting Director | — | female |
| Monpat Bhumrattanajarin | Head of Internal Audit | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SPA.BK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
